770 results on '"K Kraft"'
Search Results
202. Antihypertensiver Effekt von einmal täglich 2,5 mg Cilazapril bei Patienten, die auf ACE- Hemmer ansprechen: Beurteilung durch ambulante 24stündige Blutdrucküberwachung
- Author
-
K.O. Stumpe, K. Kraft, and A. Schneeweiss
- Subjects
musculoskeletal diseases ,biology ,business.industry ,Angiotensin-converting enzyme ,Pharmacology ,Cilazapril ,humanities ,body regions ,Enzyme inhibitor ,biology.protein ,Medicine ,Pharmacology (medical) ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
An 12 Patienten mit milder bis mittelschwerer Hypertonie, von denen bekannt war, dass sie auf ACE-Hemmer ansprechen, wurde die antihypertensive Wirkung des neuen ACE-Hemmers Cilazapril durch ambulante
- Published
- 1993
- Full Text
- View/download PDF
203. Ciliate pellicular proteome identifies novel protein families with characteristic repeat motifs that are common to alveolates
- Author
-
Geoffrey I. McFadden, Sven B. Gould, Christopher D. Goodman, Andrew Cassin, Antony Bacic, Kristina L. Ford, Lesleigh G. K. Kraft, Ross F. Waller, and Giel G. van Dooren
- Subjects
Oral apparatus ,Male ,Protein family ,Proteome ,Recombinant Fusion Proteins ,Molecular Sequence Data ,Cell Culture Techniques ,Protozoan Proteins ,Biology ,Alveolate ,Tetrahymena thermophila ,Evolution, Molecular ,Protein structure ,parasitic diseases ,Genetics ,Humans ,Amino Acid Sequence ,Cloning, Molecular ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Phylogeny ,Repetitive Sequences, Nucleic Acid ,Inner membrane complex ,Cell Membrane ,Membrane Proteins ,Fibroblasts ,biology.organism_classification ,Cell biology ,Membrane protein ,Apical complex ,Sequence Alignment ,Toxoplasma - Abstract
The pellicles of alveolates (ciliates, apicomplexans, and dinoflagellates) share a common organization, yet perform very divergent functions, including motility, host cell invasion, and armor. The alveolate pellicle consists of a system of flattened membrane sacs (alveoli, which are the defining feature of the group) below the plasma membrane that is supported by a membrane skeleton as well as a network of microtubules and other filamentous elements. We recently showed that a family of proteins, alveolins, are common and unique to this pellicular structure in alveolates. To identify additional proteins that contribute to this structure, a pellicle proteome study was conducted for the ciliate Tetrahymena thermophila. We found 1,173 proteins associated with this structure, 45% (529 proteins) of which represented novel proteins without matches to other functionally characterized proteins. Expression of four newly identified T. thermophila pellicular proteins as green fluorescent protein-fusion constructs confirmed pellicular location, and one new protein located in the oral apparatus. Bioinformatic analysis revealed that 21% of the putative pellicular proteins, predominantly the novel proteins, contained highly repetitive regions with strong amino acid biases for particular residues (K, E, Q, L, I, and V). When the T. thermophila novel proteins were compared with apicomplexan genomic data, 278 proteins with high sequence similarity were identified, suggesting that many of these putative pellicular components are shared between the alveolates. Of these shared proteins, 126 contained the distinctive repeat regions. Localization of two such proteins in Toxoplasma gondii confirmed their role in the pellicle and in doing so identified two new proteins of the apicomplexan invasive structure--the apical complex. Screening broadly for these repetitive domains in genomic data revealed large and actively evolving families of such proteins in alveolates, suggesting that these proteins might underpin the diversity and utility of their unique pellicular structure.
- Published
- 2010
204. Obstructive sleep apnea syndrome and postoperative complications: clinical use of the STOP-BANG questionnaire
- Author
-
Ritu G. Grewal, David Reiter, Walter K. Kraft, Dimitri Markov, Rodrigo Cavallazzi, Karl Doghramji, Amyn Hirani, Benjamin E. Leiby, Tajender S. Vasu, and Thomas A. Witkowski
- Subjects
Male ,medicine.medical_specialty ,Preoperative care ,Risk Assessment ,Severity of Illness Index ,Body Mass Index ,Cohort Studies ,Postoperative Complications ,Internal medicine ,Surveys and Questionnaires ,Severity of illness ,Preoperative Care ,medicine ,Humans ,Obesity ,Elective surgery ,Sleep Apnea, Obstructive ,business.industry ,Age Factors ,Sleep apnea ,Apnea ,General Medicine ,Length of Stay ,Middle Aged ,medicine.disease ,Obstructive sleep apnea ,Otorhinolaryngology ,Anesthesia ,Surgical Procedures, Operative ,Surgery ,Female ,medicine.symptom ,business ,Body mass index ,Cohort study - Abstract
To determine whether high risk scores on preoperative STOP-BANG (Snoring, Tiredness during daytime, Observed apnea, high blood Pressure, Body mass index, Age, Neck circumference, Gender) questionnaires during preoperative evaluation correlated with a higher rate of complications of obstructive sleep apnea syndrome (OSAS).Historical cohort study.Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.Adult patients undergoing elective surgery at a tertiary care center who were administered the STOP-BANG questionnaire for 3 consecutive days in May 2008.Number and types of complications.A total of 135 patients were included in the study, of whom 56 (41.5%) had high risk scores for OSAS. The mean (SD) age of patients was 57.9 (14.4) years; 60 (44.4%) were men. Patients at high risk of OSAS had a higher rate of postoperative complications compared with patients at low risk (19.6% vs 1.3%; P.001). Age, American Society of Anesthesiologists class of 3 or higher, and obesity were associated with an increased risk of postoperative complications. On multivariate analysis, high risk of OSAS and American Society of Anesthesiologists class 3 or higher were associated with higher odds of complications.The STOP-BANG questionnaire is useful for preoperative identification of patients at higher than normal risk for surgical complications, probably because it identifies patients with occult OSAS.
- Published
- 2010
205. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome
- Author
-
Walter K, Kraft, Kevin, Dysart, Jay S, Greenspan, Eric, Gibson, Karol, Kaltenbach, and Michelle E, Ehrlich
- Subjects
Adult ,Male ,Dose-Response Relationship, Drug ,Morphine ,Narcotic Antagonists ,Administration, Sublingual ,Infant, Newborn ,Length of Stay ,Severity of Illness Index ,Buprenorphine ,Treatment Outcome ,Pregnancy ,Phenobarbital ,Cytomegalovirus Infections ,Opiate Substitution Treatment ,Birth Weight ,Humans ,Hypnotics and Sedatives ,Female ,Neonatal Abstinence Syndrome - Abstract
More than half of infants exposed to opioids in utero develop neonatal abstinence syndrome (NAS) of severity to require pharmacological therapy. Current treatments are associated with prolonged hospitalization. We sought to optimize the dose of sublingual buprenorphine in the treatment of NAS.Randomized, Phase 1, open-label, active-control clinical trial comparing sublingual buprenorphine to oral morphine.Large, urban, tertiary care hospital.Twenty-four term infants requiring pharmacological treatment for NAS.Outcomes were neonatal safety, length of treatment and length of hospitalization.Sublingual buprenorphine was safe and effective. Infants treated with buprenorphine had a 23-day length of treatment compared to 38 days for those treated with morphine (P = 0.01), representing a 40% reduction. Length of hospital stay in the buprenorphine group was reduced 24%, from 42 to 32 days (P = 0.05).Sublingual buprenorphine was safe in NAS, with a substantial efficacy advantage over standard of care therapy with oral morphine.
- Published
- 2010
206. US and MRI of a pharyngeal hairy polyp with pathological correlation
- Author
-
Catherine Cullinane, L C Knight, and Jeannette K. Kraft
- Subjects
medicine.medical_specialty ,Polyps ,otorhinolaryngologic diseases ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Pathological correlation ,Neuroradiology ,Ultrasonography ,Developmental Malformations ,Respiratory distress ,business.industry ,fungi ,Infant, Newborn ,food and beverages ,Nasopharyngeal obstruction ,Anatomy ,Magnetic Resonance Imaging ,digestive system diseases ,Airway Obstruction ,stomatognathic diseases ,Nasopharyngeal Diseases ,Pediatrics, Perinatology and Child Health ,Pharynx ,Female ,Radiology ,business - Abstract
Hairy polyps are uncommon developmental malformations of the oropharynx. They are frequently pedunculated and can cause respiratory distress in the neonate. Hairy polyps are usually diagnosed with MRI but can be well seen at US. To our knowledge, the sonographic features have not been previously reported.
- Published
- 2010
207. Clinical pharmacology: a paradigm for individualized medicine
- Author
-
Scott A. Waldman, Timothy J. Nelson, Walter K. Kraft, and Andre Terzic
- Subjects
medicine.medical_specialty ,Clinical pharmacology ,business.industry ,Drug discovery ,Biochemistry (medical) ,Clinical Biochemistry ,MEDLINE ,Context (language use) ,Pharmacology ,Molecular diagnostics ,law.invention ,law ,Drug Discovery ,Medicine ,Identification (biology) ,Personalized medicine ,Disease management (health) ,business ,Intensive care medicine - Abstract
Individualized medicine provides a powerful engine revolutionizing the practice of clinical pharmacology, tailoring genetic and molecular profiles of patients to improve therapeutic specificity, reduce treatment variability and minimize adverse drug events. In that context, advances in individualized medicine have transformed the science of clinical pharmacology and therapeutics from drug discovery through identification of drugable targets, development through stratification of disease risk, regulation through identifying pathways mediating off-target effects and utilization through personalizing drug regimens. This revolution in fundamental and applied therapeutics has entrained an evolution in biology and medicine. Insights in the mechanistic basis of cell, tissue and organ function, and their interface with the environment are being translated to define disease risk, identify processes mediating disease susceptibility, target mechanism-based therapies, and tailor prevention and control paradigms, providing previously unanticipated opportunities for patient-specific disease management. The emerging field of individualized medicine is transforming the practice of clinical pharmacology, driving the leading edge of discovery from the laboratory bench to the evidence basis of practice in the clinic, extending to populations, to transform healthcare and create predictive, personalized and pre-emptive solutions for tailored patient-specific therapeutic strategies.
- Published
- 2010
208. Experimental therapeutics: a paradigm for personalized medicine
- Author
-
Scott A. Waldman, Walter K. Kraft, Timothy J. Nelson, and Andre Terzic
- Subjects
medicine.medical_specialty ,Drug discovery ,business.industry ,General Neuroscience ,MEDLINE ,General Medicine ,Precision medicine ,General Biochemistry, Genetics and Molecular Biology ,Pharmaceutical Preparations ,Drug Discovery ,medicine ,Humans ,Medical physics ,Disease ,Personalized medicine ,General Pharmacology, Toxicology and Pharmaceutics ,Precision Medicine ,business ,Biomarkers ,Research Articles - Published
- 2010
209. Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects
- Author
-
John A. Wagner, Waldemar Radziszewski, Jane Royalty, Jules I. Schwartz, Chodakewitz Jeffrey A, Walter K. Kraft, Fang Liu, Patricia Jumes, Aimee Dallob, Christine McCrary Sisk, and Eseng Lai
- Subjects
Adult ,Male ,medicine.medical_specialty ,Bleeding Time ,Indoles ,Adolescent ,Platelet Aggregation ,Pharmacology ,Niacin ,Sensitivity and Specificity ,Thromboxane receptor ,Placebos ,chemistry.chemical_compound ,Young Adult ,Double-Blind Method ,Bleeding time ,Reference Values ,Internal medicine ,medicine ,Humans ,Platelet ,Receptor ,Aged ,Cross-Over Studies ,medicine.diagnostic_test ,Dose-Response Relationship, Drug ,business.industry ,Antagonist ,Hematology ,General Medicine ,Middle Aged ,Endocrinology ,chemistry ,Delayed-Action Preparations ,Female ,Collagen ,business ,Laropiprant ,Ex vivo - Abstract
Laropiprant (LRPT) has been shown to reduce flushing symptoms induced by niacin and has been combined with niacin for treatment of dyslipidemia. LRPT, a potent PGD(2) receptor (DP1) antagonist that also has modest activity at the thromboxane receptor (TP), may have the potential to alter platelet function either by enhancing platelet reactivity through DP1 antagonism or by inhibiting platelet aggregation through TP antagonism. Studies of platelet aggregation ex vivo and bleeding time have shown that LRPT, at therapeutic doses, does not produce clinically meaningful alterations in platelet function. The present study was conducted to assess platelet reactivity to LRPT using methods that increase the sensitivity to detect changes in platelet responsiveness to collagen and ADP. The responsiveness of platelets was quantified by determining the EC(50) of collagen to induce platelet aggregation ex vivo. At 24 hours post-dose on Day 7, the responsiveness of platelets to collagen-induced aggregation was similar following daily treatment with extended-release niacin (ERN) 2 g/LRPT 40 mg or ERN 2 g. At 2 hours post-dose on Day 7, the EC(50) for collagen-induced platelet aggregation was approximately two-fold higher in the presence of LRPT, consistent with a small, transient inhibition of platelet responsiveness to collagen. There was no clinical difference between treatments for bleeding time, suggesting that this small effect on collagen EC(50) does not result in a clinically meaningful alteration of platelet function in vivo. The results of this highly sensitive method demonstrate that LRPT does not enhance platelet reactivity when given alone or with ERN.
- Published
- 2010
210. Hypertension
- Author
-
K. Kraft, A. Löw-Kröger, H. Frerick, N. Schenk, and U. Schmidt
- Subjects
Pharmacology ,Drug ,medicine.medical_specialty ,business.industry ,media_common.quotation_subject ,medicine.disease ,Pharmacotherapy ,Chronic disease ,Work (electrical) ,Medicine ,Medical emergency ,Cardiology and Cardiovascular Medicine ,business ,Intensive care medicine ,Road traffic ,media_common - Abstract
Physical and/or mental deficiencies caused by illness and someting by drug therapy may impair the patient's condition at work and when driving. Therefore, the influence of drug theropy, particularly that of chronic disease, on patients who drive should be considered
- Published
- 1992
- Full Text
- View/download PDF
211. Diurnal variation of the human adipose transcriptome and the link to metabolic disease
- Author
-
Walter K. Kraft, Amy Leonardson, Bernard Fine, Christopher M. Wright, Andrey Loboda, Mark D. Ferguson, Pek Yee Lum, John Lamb, Chunsheng Zhang, Hongyue Dai, Xia Yang, Michael Nebozhyn, Ira Chalikonda, Howard E. Greenberg, Eric E. Schadt, Jeffrey I. Joseph, Valur Emilsson, Mark Morris, and Yudong He
- Subjects
lcsh:Internal medicine ,medicine.medical_specialty ,lcsh:QH426-470 ,Oncology and Carcinogenesis ,Adipose tissue ,Biology ,Medical Biochemistry and Metabolomics ,Transcriptome ,Affordable and Clean Energy ,Weight loss ,Clinical Research ,Internal medicine ,Gene expression ,medicine ,Genetics ,2.1 Biological and endogenous factors ,Genetics(clinical) ,Circadian rhythm ,Obesity ,Aetiology ,lcsh:RC31-1245 ,Genetics (clinical) ,Metabolic and endocrine ,Morning ,Nutrition ,Genetics & Heredity ,Diurnal temperature variation ,CLOCK ,lcsh:Genetics ,Endocrinology ,medicine.symptom ,Research Article ,Biotechnology - Abstract
Background Circadian (diurnal) rhythm is an integral part of the physiology of the body; specifically, sleep, feeding behavior and metabolism are tightly linked to the light-dark cycle dictated by earth's rotation. Methods The present study examines the effect of diurnal rhythm on gene expression in the subcutaneous adipose tissue of overweight to mildly obese, healthy individuals. In this well-controlled clinical study, adipose biopsies were taken in the morning, afternoon and evening from individuals in three study arms: treatment with the weight loss drug sibutramine/fasted, placebo/fed and placebo/fasted. Results The results indicated that diurnal rhythm was the most significant driver of gene expression variation in the human adipose tissue, with at least 25% of the genes having had significant changes in their expression levels during the course of the day. The mRNA expression levels of core clock genes at a specific time of day were consistent across multiple subjects on different days in all three arms, indicating robust diurnal regulation irrespective of potential confounding factors. The genes essential for energy metabolism and tissue physiology were part of the diurnal signature. We hypothesize that the diurnal transition of the expression of energy metabolism genes reflects the shift in the adipose tissue from an energy-expending state in the morning to an energy-storing state in the evening. Consistent with this hypothesis, the diurnal transition was delayed by fasting and treatment with sibutramine. Finally, an in silico comparison of the diurnal signature with data from the publicly-available Connectivity Map demonstrated a significant association with transcripts that were repressed by mTOR inhibitors, suggesting a possible link between mTOR signaling, diurnal gene expression and metabolic regulation. Conclusion Diurnal rhythm plays an important role in the physiology and regulation of energy metabolism in the adipose tissue and should be considered in the selection of novel targets for the treatment of obesity and other metabolic disorders.
- Published
- 2009
212. ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Author
-
Frank T. Leone and Walter K. Kraft
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Pulmonary disease ,medicine.disease ,business ,Asthma - Published
- 2009
- Full Text
- View/download PDF
213. ASSOCIATE EDITORS
- Author
-
Laurence J. Egan, Jean-Luc Elghozi, Arshad Jahangir, Garvan C. Kane, Walter K. Kraft, Lionel D. Lewis, Jason D. Morrow, and Leonid V. Zingman
- Published
- 2009
- Full Text
- View/download PDF
214. Check-Up-Medizin
- Author
-
D. Abeck, S. Wärntges, M. Oeff, A. Ernst, B. Dannewitz, W. J. Kox, P. Cullen, H.J. Greten, T. Hinrichs, C.-M. Muth, N. Worm, E. Stapelfeldt, H. Drexler, F. Mußhoff, Uwe Nixdorff, W. Jilg, J. Siegrist, B. Madea, H. Mück, S. Schirp, F. Wagner, F.-M. Köhn, G. Kluge, K. Kraft, G. Mehlhorn, M. Mück-Weymann, R. Gerzer, D. Domagk, J. Pantel, C. Gawrilow, C. M. Bamberger, K. Riemann, G. Michelson, R. Schulz-Wendtland, P. Sefrin, J. Wessling, H. Rübben, M. Möhrenschlager, M. Hensel, G. Schulz, Y. K. Maratos, M. Halle, K. Tetzlaff, E. Gramenz, G. Jacobi, U. Nixdorff, W. Blank, V. Tesky, F. Kiefer, W. Kindermann, P. Platen, P. Eickholz, L.S. Griffith, H. C. Diener, S. Schwarz, H. Binder, J. H. Ficker, D.H.W. Grönemeyer, T. H. Fink, B. Meurer, E. Stockmann, J. Mutschler, and M. W. Beckmann
- Published
- 2009
- Full Text
- View/download PDF
215. CONTRIBUTORS
- Author
-
Darrell R. Abernethy, Viola Andresen, Arthur J. Atkinson, Michel Azizi, Helen L. Baron, Carol L. Beck, Atta Behfar, Rodney Bell, Eduardo E. Benarroch, Neal L. Benowitz, Wade Berrettini, Joseph S. Bertino, Alfredo Bianchi, Michael J. Blake, Ann F. Bolger, Glenn D. Braunstein, David Brock, Peter A. Calabresi, Michael Camilleri, Mark Chaballa, Omer Chaudhry, Doo-Sup Choi, Bart L. Clarke, Mary E. Dankert, Dawood Darbar, Mark Davis, Daniel Deck, Jan de Gans, Joseph A. DeSimone, Robert B. Diasio, André Diedrich, Darin D. Dougherty, Laurence J. Egan, Claudine El-Beyrouty, Jean-Luc Elghozi, Arthur M. Feldman, Joanne Filicko-O'Hara, Charles W. Flexner, Neal Flomenberg, Joseph F. Foss, Adam M. Frank, Mark A. Frye, Kishor Gandhi, Joseph Genebriera, William R. Gilliland, Jean Gray, Benjamin M. Greenberg, Naomi Gronich, Dolores Grosso, Andrew R. Haas, Wael N. Haidar, Christine A. Haller, Daniel K. Hall-Flavin, Lisa Hamaker, William F. Harvey, James W. Heitz, Steven K. Herrine, Raymond J. Hohl, Sarah A. Holstein, Dorothy Holt, Linda S. Hostelley, Eric R. Houpt, Shiew-Mei Huang, David J. Hunter, Serge Jabbour, Robert M. Jacobson, Arshad Jahangir, Michael A. Jenike, Kristine E. Johnson, Victor M. Karpyak, Gregory L. Kearns, Richard M. Keating, Michael P. Keith, Sundeep Khosla, Julia Kirchheiner, Walter J. Koch, Bruce C. Kone, Walter K. Kraft, Robert F. Kushner, Christine Laine, Richard L. Lalonde, Kiwon Lee, Teofilo Lee-Chiong, Frank T. Leone, Lawrence J. Lesko, Barbara A. Levey, Lionel D. Lewis, Joseph Loscalzo, Anastasios Lymperopoulos, Joseph P. Lynch, Christian Maaser, Viqar Maria, Paul E. Marik, Marco A. Maurtua, Steven E. McKenzie, Alex Mejia, Michael C. Milone, Scott Mintzer, Thomas P. Moyer, David A. Mrazek, Matthew S. Murphy, Filip Mussen, Jasmine Nabi, Victor J. Navarro, Timothy J. Nelson, Dionissios Neofytos, Kathleen A. Neville, Myaing Nyunt, Timothy O'Brien, Inna G. Ovsyannikova, Chi-Un Pae, James F. Pagel, Ashwin A. Patkar, Kah Whye Peng, Edith A. Perez, Ronald C. Petersen, Paul A. Pham, Jennifer M. Phillips, Carissa Pineda, Mark R. Pittelkow, Pierre-François Plouin, Christopher V. Plowe, Gregory A. Poland, Azad Raiesdana, John N. Ratchford, Nandi J. Reddy, Michael D. Reed, Douglas J. Rhee, Robert A. Rizza, David Robertson, Dan M. Roden, Anne M. Rompalo, Simona Rossi, Vivek Roy, Stephen J. Russell, Steven Ryder, Muhammad Wasif Saif, Rajiv Saini, Kyoko Sato, Kathryn M. Schak, Matthias Schwab, Kumar Sharma, Robert G. Sharrar, Leslie M. Shaw, Ludy Shih, Steven J. Siegel, Peter A. Singer, David R. Staskin, Dale W. Stovall, Jerome F. Strauss, Paul V. Targonski, Daniel Tarsy, William S. Tasman, Robert Temple, Andre Terzic, John E. Tetzlaff, Pritish K. Tosh, Erev E. Tubb, Kathleen Uhl, Patrick Vallance, Diederik van de Beek, Adrian Vella, Eugene R. Viscusi, John L. Wagner, Scott A. Waldman, Philip B. Wedegaertner, Alan J. Wein, Ethan Weiner, Richard Weinshilboum, Martijn Weisfelt, Lisa G. Winston, Run Yu, and Ying Zhang
- Published
- 2009
- Full Text
- View/download PDF
216. ACID REFLUX AND ULCER DISEASE
- Author
-
Walter K. Kraft and Alex Mejia
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Reflux ,Ulcer disease ,medicine ,business ,Gastroenterology - Published
- 2009
- Full Text
- View/download PDF
217. Rheumatic diseases in Ayurveda: A historical perspective
- Author
-
G. Ulrich-Merzenich, K. Kraft, and L. M. Singh
- Subjects
Autoimmune disease ,medicine.medical_specialty ,business.industry ,Immunology ,Perspective (graphical) ,medicine.disease ,Surgery ,Rheumatology ,Immunopathology ,Rheumatoid arthritis ,medicine ,Immunology and Allergy ,Pharmacology (medical) ,Intensive care medicine ,business - Published
- 1999
- Full Text
- View/download PDF
218. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting
- Author
-
Sofia Medvedev, Walter K. Kraft, Isaac R. Whitman, Constantine Daskalakis, David J. Whellan, Sam Hohmann, and Dae Hyun Kim
- Subjects
Male ,medicine.medical_specialty ,Serotonin reuptake inhibitor ,Hemorrhage ,Coronary Artery Disease ,Coronary artery disease ,Risk Factors ,Internal medicine ,Clinical endpoint ,Medicine ,Humans ,Hospital Mortality ,Coronary Artery Bypass ,Depression (differential diagnoses) ,Aged ,Retrospective Studies ,Depressive Disorder ,business.industry ,digestive, oral, and skin physiology ,Retrospective cohort study ,Odds ratio ,Middle Aged ,medicine.disease ,Data Interpretation, Statistical ,Cardiology ,Antidepressant ,Female ,Safety ,Cardiology and Cardiovascular Medicine ,business ,Complication ,Selective Serotonin Reuptake Inhibitors - Abstract
Selective serotonin reuptake inhibitors (SSRIs) are commonly used in patients with coronary artery disease and depression, but they have been reported to increase the risk for bleeding. However, data on the short-term outcomes comparing SSRI and non-SSRI antidepressant use after coronary artery bypass grafting (CABG) are limited. A retrospective analysis was conducted of 1,380 adults who received any antidepressants before CABG from 2003 to 2006 at academic medical centers participating in the University HealthSystem Consortium. The primary end point was defined as a composite of in-hospital mortality or any bleeding events, including postprocedural hemorrhage or hematoma, gastrointestinal hemorrhage, and reopening of surgical site. A total of 1,076 adults (78%) received SSRIs. After controlling for propensity of receiving SSRIs compared with non-SSRIs, no significant differences were found in the primary end point (9.4% vs 8.2%, adjusted odds ratio [OR] 1.03, 95% confidence interval [CI] 0.60 to 1.78), any bleeding events (6.5% vs 7.2%, OR 0.93, 95% CI 0.50 to 1.76), or in-hospital mortality (3.1% vs 2.3%, OR 0.88, 95% CI 0.47 to 1.65). There was no increased risk associated with SSRI use when the analysis was restricted to patients who received antiplatelet and anticoagulant therapy for acute coronary syndromes (OR 1.03, 95% CI 0.40 to 2.61) and when examined by age, gender, nonsteroidal anti-inflammatory drug use, and type of CABG (on pump or off pump). In conclusion, compared with non-SSRIs, the preoperative use of SSRIs does not seem to increase the risk for bleeding or in-hospital mortality after CABG.
- Published
- 2008
219. [Effects of a telephone intervention in patients with type 2 diabetes]
- Author
-
H, Richter, K, Kraft, H, Kleinwechter, N, Demandt, G, Meincke, A, Dabelstein, and B, Weisser
- Subjects
Male ,Diabetes Mellitus, Type 2 ,Cardiovascular Diseases ,Risk Factors ,Surveys and Questionnaires ,Health Behavior ,Humans ,Female ,Middle Aged ,Motor Activity ,Exercise ,Life Style ,Telephone - Abstract
While there are evermore therapeutic options, a continuous rise in the prevalence of type 2 diabetes mellitus has been demonstrated in epidemiological studies and is leading to an increasing financial burden on health care systems. It has been shown in a number of studies that health-related lifestyle may be influenced by a telephone intervention program.The effect of a telephone intervention on physical activity and other important cardiovascular risk factors was investigated over a period of three months in patients with type 2 diabetes. Those in the intervention group (n=22) were phoned once weekly and only matters concerning their physical activity were discussed. The patients in a matching control group (n=20) were not phoned.Physical activity increased in the intervention group with a significant difference when compared to the control group at the end of the three months' intervention. At the end of the intervention weight, body mass index, waist circumference, systolic blood pressure, triglycerides and fasting blood sugar where either significantly different between the intervention and control groups (absolute values) or showed a significantly greater decrease in the intervention group. In addition there was a tendency (not statistically significant) towards an improvement in the intervention group regarding other risk factors (body fat, diastolic blood pressure, total cholesterol, LDL, HDL, HbA1c).These results demonstrate that a telephone intervention can increase physical activity and reduce cardiovascular risk factors. As a result it may reduce health care-related costs.
- Published
- 2008
220. Contributors
- Author
-
INTEKHAB AHMED, ROBERT F. ATKINS, RODNEY D. BELL, BARTOLOME R. CELLI, GRETCHEN DIEMER, JOHN A. EVANS, FREDERICK M. FELLIN, JAMES FINK, DAVID G. FORCIONE, LAWRENCE S. FRIEDMAN, KEVIN FURLONG, DEBORAH T. GLASSMAN, MARVIN E. GOZUM, MARK G. GRAHAM, BRENDA HOFFMAN, DANIEL K. HOLLERAN, SERGE JABBOUR, GREGORY C. KANE, BARBARA KNIGHT, WALTER K. KRAFT, JANINE V. KYRILLOS, KENNETH LIEBMAN, MICHAEL F. LUBIN, BRIAN F. MANDELL, TRACY MCGOWAN, ROBERT E. MEASLEY, L. BERNARDO MENAJOVSKY, GENO J. MERLI, GREGORY MOKRYNSKI, JOSEPH M. MONTELLA, JACQUELINE G. O'LEARY, JAVAD PARVIZI, JEFFREY M. RIGGIO, ELIZABETH TEPEROV, GEORGE L. TZANIS, JENNY Y. WANG, HOWARD H. WEITZ, SUSAN E. WEST, and BARRY S. ZIRING
- Published
- 2008
- Full Text
- View/download PDF
221. Managing Medication in the Perioperative Period
- Author
-
Gretchen Diemer and Walter K. Kraft
- Subjects
medicine.medical_specialty ,business.industry ,Emergency medicine ,medicine ,Perioperative ,business - Published
- 2008
- Full Text
- View/download PDF
222. Ethanol Pharmacokinetics in Neonates Secondary to Medication Administration
- Author
-
Paul S. Monks, Elizabeth Marek, Tara E. DeCerbo, Susan C. Adeniyi-Jones, Rebecca Cordell, Lindsey Roke, and Walter K. Kraft
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Pharmacokinetics ,business.industry ,030225 pediatrics ,Anesthesia ,Pediatrics, Perinatology and Child Health ,Medicine ,030212 general & internal medicine ,Medication administration ,business - Published
- 2016
- Full Text
- View/download PDF
223. [Primary malignant melanoma of the parotid gland: a case report and review of the literature]
- Author
-
H, Maier, G, Mühlmeier, K, Kraft, N M, Blumstein, and M, Tisch
- Subjects
Male ,Treatment Outcome ,Humans ,Middle Aged ,Melanoma ,Parotid Neoplasms - Abstract
Malignant melanomas (MMs) of the parotid gland are relatively uncommon. They occur almost invariably as metastases from a primary tumour located in the region of the scalp or the mucous membranes of the nose, paranasal sinuses, or throat. Primary MMs arising in the parotid gland are extremely rare. It is assumed that they originate in the glandular tissue or in intraglandular lymph nodes. We present a case report and review of the literature on the diagnosis, treatment, and prognosis of intraparotid malignant melanoma. Diagnosis is based primarily on B-scan ultrasonography and fine-needle aspiration cytology. Patients with a cytological diagnosis of MM are further evaluated by magnetic resonance imaging and positron emission tomography and receive a thorough ear-nose-throat and dermatological examination. The treatment of choice is total parotidectomy and selective neck dissection. The effectiveness of adjuvant treatments such as radiotherapy, chemotherapy, or immunotherapy remains controversial. Patients with primary MMs of the parotid gland appear to have a better prognosis than those with parotid metastases from melanomas of the skin or mucous membranes.
- Published
- 2007
224. A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients
- Author
-
Trevor R. Baybutt, Laurence C. Eisenlohr, Michael J. Mastrangelo, Scott A. Waldman, Yaa Oppong, Terry Hyslop, Nancy L. Lewis, Takami Sato, Walter K. Kraft, Scott D. Goldstein, Ronald E. Myers, Adam E. Snook, and Vitali Alexeev
- Subjects
Pharmacology ,Cancer Research ,business.industry ,Colorectal cancer ,viruses ,Immunology ,Guanylate cyclase 2C ,Bioinformatics ,medicine.disease ,Molecular biology ,Epitope ,law.invention ,Phase i study ,Paracrine signalling ,Oncology ,law ,Second messenger system ,Poster Presentation ,Recombinant DNA ,Molecular Medicine ,Immunology and Allergy ,Medicine ,Receptor ,business - Abstract
Meeting abstracts Ad5-GUCY2C-PADRE is a replication-deficient human type 5 recombinant adenovirus (Ad5) vaccine encoding guanylyl cyclase C (GUCY2C) fused to the PAn DR Epitope (PADRE). GUCY2C, a paracrine hormone receptor producing the second messenger cyclic GMP (cGMP), is selectively expressed
- Published
- 2015
225. A screening tool to identify FIT geriatric oncology patients
- Author
-
Kristine Swartz, Benjamin E. Leiby, Amy R. MacKenzie, Andrew E. Chapman, Joshua Schoppe, Ashwin Reddy Sama, and Walter K. Kraft
- Subjects
Gerontology ,Cancer Research ,medicine.medical_specialty ,business.industry ,health care facilities, manpower, and services ,Vulnerable elders ,Vulnerability ,social sciences ,humanities ,Test (assessment) ,Oncology ,Geriatric oncology ,Physical therapy ,medicine ,Screening tool ,business - Abstract
e20532 Background: A Vulnerable Elders Survey (VES 13) score of ≥ 3 has been validated to predict vulnerability for community elders but not geriatric oncology patients. A test to accurately identi...
- Published
- 2015
- Full Text
- View/download PDF
226. Man with syncopal episodes and abnormal chest radiograph findings. Plombage therapy
- Author
-
M K, Leonard, C K, Kraft, and R F, Corpe
- Subjects
Male ,Humans ,Lung ,Tuberculosis, Pulmonary ,Pneumonolysis ,Aged - Published
- 2006
227. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects
- Author
-
Keith Gottesdiener, Glenn Frick, Paul Statkevich, Walter K. Kraft, Amy O. Johnson-Levonas, Patrick Larson, Arthur J. Bergman, Gail Murphy, John F. Paolini, Howard E. Greenberg, Larisa Reyderman, Joanne Burke, and Teddy Kosoglou
- Subjects
Adult ,Male ,Cmax ,Pharmacology ,Pharmacokinetics ,Ezetimibe ,medicine ,Humans ,Pharmacology (medical) ,Drug Interactions ,Dosing ,Cross-Over Studies ,Dose-Response Relationship, Drug ,business.industry ,Anticholesteremic Agents ,Healthy subjects ,Crossover study ,Confidence interval ,Dose–response relationship ,Area Under Curve ,Cyclosporine ,Azetidines ,Female ,Drug Monitoring ,business ,Immunosuppressive Agents ,medicine.drug - Abstract
This single-center, open-label, 2-period crossover study investigated the effects of multiple-dose ezetimibe (EZE) on a single dose of cyclosporine (CyA). Healthy subjects received 2 treatments in random order with a 14-day washout: (1) CyA 100 mg alone and (2) EZE 20 mg for 7 days with CyA 100 mg coadministered on day 7; EZE 20 mg alone was administered on day 8. AUC(0-last) and Cmax geometric mean ratios (90% confidence interval) for ([CyA + EZE]/CyA alone) were 1.15 (1.07, 1.25) and 1.10 (0.97, 1.26), respectively. Tmax (approximately 1.3 hours) was similar with and without EZE (P >.200). Mean CyA exposure slightly increased (approximately 15%) with multiple-dose EZE 20 mg; however, this value was contained within (0.80, 1.25). The implications for chronic EZE dosing within the usual clinical paradigm of chronic CyA dosing have not been established; caution is recommended when using these agents concomitantly. CyA concentrations should be monitored in patients receiving EZE and CyA.
- Published
- 2006
228. Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation
- Author
-
Irina Kakhniashvili, Joanne Filicko, Neal Flomenberg, and Walter K. Kraft
- Subjects
Adult ,Male ,Lymphocyte ,medicine.medical_treatment ,T-Lymphocytes ,Antigens, CD34 ,Hematopoietic stem cell transplantation ,Immunoglobulin G ,Donor lymphocyte infusion ,Lymphocyte Depletion ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Medicine ,Humans ,Transplantation, Homologous ,Aged ,Antilymphocyte Serum ,Transplantation ,biology ,business.industry ,Hematopoietic Stem Cell Transplantation ,Immunosuppression ,Hematology ,Immune reconstitution ,Middle Aged ,3. Good health ,medicine.anatomical_structure ,T-cell depletion ,030220 oncology & carcinogenesis ,Hematologic Neoplasms ,Immunology ,biology.protein ,Female ,Antithymocyte globulin ,Antibody ,business ,Antilymphocyte globulin ,Immunosuppressive Agents ,030215 immunology - Abstract
Antithymocyte globulins (ATG) are purified, concentrated preparations of polyclonal immunoglobulin G from hyperimmune serum of horses or rabbits immunized with human thymus lymphocytes. Both the horse and the rabbit products induce immunosuppression as a result of lymphocyte depletion and immune modulation. The exact mechanism of action is unknown but may include T-cell clearance from the circulation and modulation of T-cell activation, homing, and cytotoxic activities. Both horse and rabbit ATG include multiple antibodies against T-cell surface antigens and have been used extensively in allogeneic hematopoietic progenitor cell transplantation (HPCT) for the treatment and prevention of graft-versus-host disease or graft rejection. To quantify the active ATG after HPCT, we developed a flow-based assay to measure residual ATG capable of binding to lymphocytes. In contrast to prior assays that measure total rabbit or horse immunoglobulin, this assay quantitates only the antibody capable of binding to lymphocytes, which presumably reflects the functionally active fraction of the xenoantiserum. Thirty patients with hematologic malignancies underwent T cell-depleted HPCT and had ATG levels assayed during the peritransplantation period. The time required for ATG levels to decay to background was quite variable (mean, 46 days; range, 14-91 days), although most patients demonstrated a rapid early clearance followed by a slower decline. The actual mean half-life was 6.8 days (range, 2.4-14.0 days). The persistence of ATG for months after administration has significant implications for the pace of immune reconstitution after transplantation and is a potentially confounding variable in any study that involves early administration of donor lymphocyte infusions or other cellular transfer. These findings indicate that ATG levels should be explicitly measured in studies that involve early donor lymphocyte administration so that proper conclusions regarding dose, safety, and efficacy can be reached.
- Published
- 2005
229. [Leiomyosarcoma of the larynx]
- Author
-
P, Gude, M, Tisch, K, Kraft, B, Danz, and H, Maier
- Subjects
Leiomyosarcoma ,Male ,Rare Diseases ,Treatment Outcome ,Humans ,Laryngectomy ,Radiotherapy, Adjuvant ,Middle Aged ,Combined Modality Therapy ,Laryngeal Neoplasms - Abstract
Leiomyosarcoma is usually found in the female genital tract, retroperitoneum, the wall of the gastrointestinal tract and subcutaneous tissues. An appearance of this malignant tumor in the larynx is extremely rare and may be difficult to diagnose. Because of its rarity, little information exists on management and prognosis. We report on a 64-year old male with a supraglottic leiomyosarcoma who was treated with supraglottic laryngectomy and postoperative radiotherapy. After 19 months the patient was well and free of disease. The most commonly used diagnostic and therapeutic procedures are analysed in a review of the 46 published cases of laryngeal leiomyosarcoma.
- Published
- 2005
230. [Ductal carcinoma of the parotid gland with the clinical picture of obstructive sialadenitis]
- Author
-
F, Hengstermann, M, Tisch, K, Kraft, and H, Maier
- Subjects
Adult ,Carcinoma, Ductal ,Diagnosis, Differential ,Male ,Submandibular Gland Diseases ,Humans ,Sialadenitis ,Parotid Neoplasms - Abstract
Salivary duct carcinoma is a highly malignant tumor. Pain, facial nerve palsy, perineural and lymphatic invasion are common findings, as well as an extensive cervical lymph node involvement and distant metastasis. However, occasionally, as in the case presented, the clinical features of this tumor may resemble obstructive sialadenitis and thus cause a delay in appropriate treatment. Although salivary duct carcinoma exhibits an unpredictable clinical course and a poor overall prognosis, total parotidectomy with neck dissection and adjunctive radiation therapy appear to be appropriate for local and regional control of this aggressive neoplasm.
- Published
- 2004
231. Laparoscopic hernia repair--TAPP or/and TEP?
- Author
-
M. Ulrich, B. J. Leibl, K. Kraft, Jochen Schwarz, Reinhard Bittner, C. Jäger, and B. Kraft
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,MEDLINE ,Hernia, Inguinal ,Comparative trial ,Vascular surgery ,medicine.disease ,Hernia repair ,Surgery ,Cardiac surgery ,Treatment Outcome ,Cardiothoracic surgery ,Recurrence ,medicine ,Humans ,Hernia ,Laparoscopy ,business ,Abdominal surgery - Abstract
Of various endoscopic hernia repair procedures, TAPP and TEP have been selected for routine use. Results from Medline research were analysed. There is a similar risk for postoperative morbidity for both techniques. The recurrence rate in large single-centre series is between 0% and 3.4%. There were numerous indications for both procedures, whereby a transperitoneal TAPP can also be applied in cases of previous preperitoneal operations. Randomised trials comparing both methods of hernia repair are lacking. Seven non-randomised studies showed no differences in recurrence rate and morbidity. In general the learning curve for is shorter in favour of TAPP repair.
- Published
- 2004
232. Syphilis testing in association with gonorrhea/chlamydia testing during a syphilis outbreak
- Author
-
Barry P. Katz, Jane Wang, Barbara E. Mahon, Marc B. Rosenman, Stephanie K. Kraft, Jaroslaw Harezlak, and Janet N. Arno
- Subjects
Sexually transmitted disease ,Adult ,Male ,medicine.medical_specialty ,Indiana ,Research and Practice ,Gonorrhea ,Comorbidity ,medicine.disease_cause ,urologic and male genital diseases ,Disease Outbreaks ,Residence Characteristics ,Risk Factors ,Medicine ,Humans ,Mass Screening ,Longitudinal Studies ,Syphilis ,Retrospective Studies ,Chlamydia ,business.industry ,Obstetrics ,Hospitals, Public ,Public health ,Public Health, Environmental and Occupational Health ,Outbreak ,Chlamydia Infections ,medicine.disease ,female genital diseases and pregnancy complications ,Syphilis Serodiagnosis ,Population Surveillance ,Immunology ,Neisseria gonorrhoeae ,Public Health Practice ,Female ,business ,Emergency Service, Hospital ,Treponematosis - Abstract
We used an electronic medical records system retrospectively to evaluate how frequently, in a public hospital and its clinics, combined gonorrhea/chlamydia tests were accompanied by a syphilis test before and during a syphilis outbreak. Among 70 330 gonorrhea/chlamydia tests (1996–2000), the proportion with a syphilis test increased from 13% (preoutbreak) to 50% (intervention period) for men and from 6% to 13% for nonpregnant women. The increased syphilis testing coincided with a multifaceted public health intervention.
- Published
- 2004
233. Vermeintliches Adenokarzinom des Samenstranges
- Author
-
M. Bodenbach, P. Adam, C. Sparwasser, H. K. Müller-Hermelink, and K. Kraft
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Urology ,Medicine ,business - Abstract
Maligne Tumoren des Samenstrangs sind eine Raritat und meist den Sarkomen zuzuordnen. Adenokarzinome werden extrem selten gefunden und sind fast immer Metastasen extragonadaler Malignome.
- Published
- 2004
- Full Text
- View/download PDF
234. [Naturopathy in rehabilitation--a logical option in the German health system]
- Author
-
K, Kraft
- Subjects
Cost-Benefit Analysis ,Germany ,Naturopathy ,Rehabilitation ,Humans ,Combined Modality Therapy ,Delivery of Health Care - Abstract
The present restructuring of the German health system is a reaction to the changing demands resulting from demographic and financial developments. In this context, an increase in patients autonomy is urgently needed which is only possible in cooperation with this group. The rehabilitative sector of the health system with its biopsychosocial model of diseases offers still heavily overlooked solutions, in particular because of its extensive use of complementary medicine, which has a high degree of acceptance among patients and the general population.
- Published
- 2004
235. [Clarification of tissue contamination in a suspected adenocarcinoma of the spermatic cord by microsatellite analysis]
- Author
-
M, Bodenbach, P, Adam, K, Kraft, H K, Müller-Hermelink, and C, Sparwasser
- Subjects
Male ,Incidental Findings ,CA-19-9 Antigen ,Biopsy ,Seminal Vesicles ,Adenocarcinoma ,Middle Aged ,Carcinoembryonic Antigen ,Specimen Handling ,Vasectomy ,Biomarkers, Tumor ,Genital Neoplasms, Male ,Equipment Contamination ,Humans ,Diagnostic Errors ,Microsatellite Repeats - Abstract
Malignant tumors of the spermatic cord are rare with primary neoplasms being mostly sarcomas. Adenocarcinomas of the spermatic cord are found extremely seldom and are predominantly metastases of extragonadal tumors. We present an asymptomatic 47-year-old patient who was referred to our clinic after a vasectomy had been performed and the histological examination had surprisingly shown adenocarcinoma of the left spermatic cord. Extensive laboratory analysis and diagnostic imaging did not demonstrate any testicular, spermatic cord, or extragonadal tumor. To exclude a mix-up of specimens, we performed DNA analysis. Microsatellite PCR clearly demonstrated the different origins of the tumor and the vasectomy specimen. Specimen mix-up or contamination may happen in any phase of surgical or pathological processing. In any case of clinical uncertainty concerning the identity of a tissue specimen, this possibility has to be taken into consideration. Microsatellite PCR can clearly identify the origin of tissue samples even on embedded material.
- Published
- 2004
236. Funktionelle und morphologische MR Bildgebung des Herzens bei 3T – intraindividueller Vergleich gegenüber einem 1, 5T System
- Author
-
SM Miller, M. E. Engels, C. C. Claussen, NS Stauder, G. L. Laub, A. K. Kraft, Ulrich Kramer, and F. Fenchel
- Subjects
Radiology, Nuclear Medicine and imaging - Published
- 2004
- Full Text
- View/download PDF
237. Ernährungstherapie
- Author
-
K. Kraft, R. Stange, S. Schmidt, H. Oberritter, H. Quirin, C. Leitzmann, G. Schönberger, H. Lützner, F. Wilhelmi de Toledo, O. Adam, M. Burkard, K. Huth, and T. Weustenfeld
- Published
- 2004
- Full Text
- View/download PDF
238. Morphologische und funktionelle Veränderungen des Herzens bei Patienten mit terminaler Niereninsuffizienz
- Author
-
SM Miller, NS Stauder, C. C. Claussen, A. K. Kraft, T. Risler, SW Wolf, MF Fenchel, and Ulrich Kramer
- Subjects
Radiology, Nuclear Medicine and imaging - Published
- 2004
- Full Text
- View/download PDF
239. Phytotherapie
- Author
-
K. Kraft, B. Uehleke, B. Rosslenbroich, R. Saller, R. Hänsel, J. G. Mayer, H. D. Peters, J. Müller, J. Windeler, J. Grünwald, D. C. Fassold, A. Walper, V. Schulz, W. D. Hübner, D. Lauda, P. Wenzel, R. Holle, R. Brandmaier, G. Schmitz, D. Melchart, Dieter Loew, A. Albrecht, W. Juretzek, S. Lange, A.-M. Beer, K. Meyer, H. Ippen, B. Beckmann, K. Unnebrink, R. Brenke, M. Dannler, R. Windhaber, and T. Richter
- Published
- 2004
- Full Text
- View/download PDF
240. Modified approach for apoptosis detection reveals changes in apoptotic processes in the seminoma-associated tissue
- Author
-
M, Abend, H U, Schmelz, K, Kraft, D, van Beuningen, and C, Sparwasser
- Abstract
Apoptosis morphology (DNA condensation) and internucleosomal DNA cleavage (TdT assay) were measured simultaneously on double fluorescence labeled testis tumor sections, employing conventional immunofluorescence microscopy. Six different apoptosis indices (Al) were determined based either solely on morphological or biochemical criteria, or on a combination of both processes. Measurements were performed in metastasized and non-metastasized seminoma, and in histological regions located distantly and associated with the tumor. Preliminary results on 19 histologies revealed that up to 66% of apoptotic cells were not detected, depending on the method used for apoptosis detection. Besides, no changes of solely morphologically defined Al was found in the different histological regions. By contrast, significant changes (p0.0004) in the different histological regions were detected when measuring Als, e.g., defined by DNA fragmentation occurring without DNA condensation in apoptotic cells. Those changes were not detected in metastasized seminoma. These data, for the first time allow a comparison of two widely used approaches for apoptosis detection. Furthermore, the results revealed differences in apoptotic processes in tissue associated with non-metastasized seminoma detectable by a modified evaluated TdT assay but not by morphological changes, although this TdT method fails to show the total amount fo apoptotic cells.
- Published
- 2003
241. The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers
- Author
-
Scott A. Waldman, Howard E. Greenberg, Nancy Fitzgerald, John N. Quiring, Don Beussink, Barry Steiger, and Walter K. Kraft
- Subjects
Budesonide ,Adult ,Male ,Chemistry, Pharmaceutical ,Cmax ,Pharmacology ,Placebo ,Bronchospasm ,Pharmacokinetics ,Medicine ,Humans ,Pharmacology (medical) ,Asthma ,Cross-Over Studies ,business.industry ,Nebulizers and Vaporizers ,medicine.disease ,Crossover study ,Bioavailability ,Bronchodilator Agents ,Female ,medicine.symptom ,business ,medicine.drug ,Half-Life - Abstract
Nanocrystal budesonide (nanobudesonide) is a suspension for nebulization in patients with steroid-responsive pulmonary diseases such as asthma. The pharmacokinetics and safety of the product were compared to those of Pulmicort Respules. Sixteen healthy volunteers were administered nanobudesonide 0.5 and 1.0 mg, Pulmicort Respules 0.5 mg, and placebo in a four-way, randomized crossover design. All nebulized formulations were well tolerated, with no evidence of bronchospasm. Nebulization times were significantly shorter for nanobudesonide compared to Pulmicort Respules. Because of a low oral bioavailability, plasma concentration of budesonide is a good marker of lung-delivered dose. The pharmacokinetics of nanobudesonide 0.5 and 1.0 mg were approximately dose proportional with respect to Cmax, AUC(0-t), and AUC(0-infinity). Nanobudesonide 0.5 mg and Pulmicort Respules 0.5 mg exhibited similar AUCs, suggesting a similar extent of pulmonary absorption. A higher Cmax was noted with nanobudesonide 0.5 mg, and the tmax was significantly different, suggesting a more rapid rate of drug delivery of nanobudesonide 0.5 mg than Pulmicort Respules. In conclusion, nebulized nanobudesonide 0.5 mg was safe in healthy volunteers, with a similar extent of absorption as Pulmicort Respules.
- Published
- 2003
242. Low-voltage power-efficient adder design
- Author
-
J. Lindner, J. Suss, M.K. Lay, Martin Margala, B.J. Jasionowski, R. Alonzo, Guoqing Chen, M. Popovic, and K. Kraft
- Subjects
Adder ,Logic synthesis ,CMOS ,Computer science ,Low-power electronics ,Hardware_INTEGRATEDCIRCUITS ,Logic simulation ,Electronic engineering ,Integrated circuit design ,Low voltage ,Power (physics) - Abstract
This paper presents results of a comprehensive comparative study of recently presented full-adder cells, examines their suitability in low-voltage low-power and high-performance applications and proposes a design methodology for a low-voltage power-efficient full adder. The study and the methodology are based on a power supply range of 1.0 V-1.8 V in 0.18 /spl mu/m CMOS technology.
- Published
- 2003
- Full Text
- View/download PDF
243. The AESOP robot system in laparoscopic surgery: increased risk or advantage for surgeon and patient?
- Author
-
B. Kraft, K. Kraft, C. Jäger, Reinhard Bittner, and B. J. Leibl
- Subjects
Laparoscopic surgery ,Adult ,Male ,medicine.medical_specialty ,Time Factors ,Adolescent ,medicine.medical_treatment ,Hernia, Inguinal ,Video-Assisted Surgery ,Statistics, Nonparametric ,law.invention ,Body Mass Index ,Randomized controlled trial ,law ,Medicine ,Humans ,Hernia ,Prospective Studies ,Laparoscopy ,Man-Machine Systems ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,General surgery ,Cholecystolithiasis ,Robotics ,Middle Aged ,medicine.disease ,Surgery ,Endoscopy ,surgical procedures, operative ,Treatment Outcome ,Cholecystectomy, Laparoscopic ,Cholecystectomy ,Female ,business ,Robotic arm ,Abdominal surgery - Abstract
The aim of this study was to examine the advantages and risks of the Automated Endoscopic System for Optical Positioning (AESOP) 3000 robot system during uncomplicated laparoscopic cholecystectomies or laparoscopic hernioplasty. In a randomized study, we examined two groups of 120 patients each with the diagnosis cholecystolithiasis respectively the unilateral inguinal hernia. We worked with the AESOP 3000, a robotic arm system that is voice-controlled by the surgeon. The subjective and objective comfort of the surgeon as well as the course and length of the operation were measured. The robot-assisted operations required significantly longer preparation and operation times. With regard to the necessary commands and manual camera corrections, the assistant group was favored. The same was true for the subjective evaluation of the surgical course by the surgeon. Our study showed that the use of AESOP during laparoscopic cholecystectomy and hernioplasty is possible in 94% of all cases. The surgeon must accept a definite loss of comfort as well as a certain loss of time against the advantage of saving on personnel.
- Published
- 2003
244. Significance of apoptosis in metastasizing testis tumors
- Author
-
Matthias Port, K. Kraft, Christoph Sparwasser, Hans U. Schmelz, and Michael Abend
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Urology ,T-Lymphocytes ,Cell ,Fluorescent Antibody Technique ,Apoptosis ,DNA Fragmentation ,Biology ,medicine.disease_cause ,Immunofluorescence ,Metastasis ,chemistry.chemical_compound ,Testicular Neoplasms ,Carcinoma, Embryonal ,medicine ,Humans ,DAPI ,Cell Nucleus ,medicine.diagnostic_test ,Tumor-infiltrating lymphocytes ,Carcinoma ,medicine.disease ,Chromatin ,medicine.anatomical_structure ,chemistry ,DNA fragmentation ,Carcinogenesis - Abstract
Testis tumors of embryonal origin (ten metastasized, six non-metastasized) and 17 mixed testis cell carcinomas (eight metastasized, nine non-metastasized) were examined. A triple immunofluorescence microscopic labeling procedure allowed the simultaneous detection of two features of apoptosis, namely morphological changes in the nucleus (DNA condensation visualized by DAPI staining) and the process of DNA fragmentation (TdT-assay) in tumor cells as well as T-cells (recognized by their CD45RO epitope). Both methods for apoptosis detection showed similar apoptotic indices (AI) only in 2.6% of all tumors. Most tumors (81.6%) showed more cells with DNA fragments than condensed chromatin, but in a number of cases (10.5%) the opposite pattern was found. These data add to the few published in vivo examinations of apoptosis using different methods and help to explain differences in the judgment of apoptosis significance for tumor prognosis. With regard to tumorigenesis, non-metastasized testis tumors were characterized by higher AIs of tumor cells and T-cells compared with metastasized tumors, which could be interpreted as a characteristic of tumors in an earlier stage of their development into an apoptosis-resistant phenotype. For the first time, in metastasized tumors a 5 to 25-fold increase of the T-cell's AIs over the corresponding AIs of tumor cells was shown. This suggests a successful counterattack of tumor cells, thus supporting the process of metastasis. However, only ten out of 33 tumors revealed these AI changes, which again highlights that tumor biology cannot be predicted by a single parametric approach. It remains to be seen whether these characteristics might be suitable for a reliable prediction of metastasis.
- Published
- 2003
245. Expression of retinoblastoma gene product in respiratory epithelium and sinonasal neoplasms: relationship with p16 and cyclin D1 expression
- Author
-
M J, Schwerer, A, Sailer, K, Kraft, K, Baczako, and H, Maier
- Subjects
Papilloma ,Carcinoma, Squamous Cell ,Humans ,Cyclin D1 ,Respiratory Mucosa ,Retinoblastoma Protein ,Cyclin-Dependent Kinase Inhibitor p16 - Abstract
Transition from G1 to S phase of the cell cycle is mediated by interactions between the Retinoblastoma gene product (pRb), p16, and cyclin D1. To determine the expression of these proteins in the sinonasal mucosa immunohistochemistry was carried out on archived tissue sections from 46 patients (37 men, 9 women, age range 17 to 82 years, median 55 years). Nuclear immunostaining for these proteins was assessed and the expression rates (percentages of immunoreactive nuclei) in normal respiratory epithelium, inverted sinonasal papillomas, cylindrical (oncocytic) sinonasal papillomas, and squamous cell carcinomas were compared. Normal respiratory epithelium showed significantly higher pRb expression in surface cells compared to basal cells (p0.05). In contrast, abundant pRb expression in surface and basal cells was detected in columnar differentiation in sinonasal papillomas and adjacent mucosa. Cuboidal and squamous metaplasia in inverted papillomas showed significantly reduced pRb expression in surface cells compared to columnar epithelium in inverted papillomas (p0.05, respectively). Expression of p16 was detected in all epithelial cell layers of normal respiratory epithelium, sinonasal papillomas, and adjacent mucosa. Cuboidal and squamous metaplasia in inverted papillomas showed increased p16 expression in surface cells compared to columnar epithelium in inverted papillomas (p0.05 between squamous metaplasia and columnar epithelium). Sinonasal squamous cell carcinomas showed the coexpression of pRb and p16. Expression rates of cyclin D1 higher than 10% were detected only in invasive carcinomas but not in carcinoma in situ, sinonasal papillomas or respiratory epithelium. Conclusively, pRb expression accompanies terminal differentiation in columnar surface cells. Expression of pRb in proliferating basal cells is present in sinonasal papillomas and adjacent mucosa but not in normal respiratory epithelium. Cuboidal and squamous metaplasia in inverted papillomas involves downregulation of pRb expression along with increased p16 expression in surface cells. Sinonasal squamous cell carcinomas coexpress pRb and p16. Overexpression of cyclin D1 in sinonasal lesions is confined to invasive squamous cell carcinomas.
- Published
- 2003
246. No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
- Author
-
Cyrus Badshah, Joan R. Butterton, Carolyn R. Cho, Fang Liu, Joanna Udo de Haes, Walter K. Kraft, Francheska Colon-Gonzalez, Ellen G. J. Hulskotte, William L. Marshall, Bhavna Kantesaria, Eugene E. Marcantonio, and Arne van Schanke
- Subjects
Transplantation ,Letermovir ,business.industry ,Drug-drug interaction ,medicine ,Hematology ,Pharmacology ,Mycophenolate ,business ,medicine.drug - Published
- 2015
- Full Text
- View/download PDF
247. Neonatal abstinence syndrome in methadone exposed infants: Role of genetic variability
- Author
-
J. K. Coller, M. R. Hutchinson, Michelle E. Ehrlich, Susan C. Adeniyi-Jones, Nona Lu, Andrea Fielder, R Haslam, and Walter K. Kraft
- Subjects
Pharmacology ,Psychiatry and Mental health ,medicine.medical_specialty ,Neonatal abstinence ,business.industry ,medicine ,Pharmacology (medical) ,Genetic variability ,Toxicology ,Psychiatry ,business ,Methadone ,medicine.drug - Published
- 2015
- Full Text
- View/download PDF
248. Diagnosis and classification of inguinal hernias
- Author
-
B. Kraft, S. Haaga, H. Kolb, K. Kraft, B. Kuckuk, B. J. Leibl, and Reinhard Bittner
- Subjects
Adult ,Male ,medicine.medical_specialty ,Hernia, Inguinal ,INGUINAL REGIONS ,Sensitivity and Specificity ,Internal medicine ,Medicine ,Humans ,Hernia ,Prospective Studies ,Physical Examination ,Aged ,Ultrasonography ,Aged, 80 and over ,Palpation ,business.industry ,Ultrasound ,Hepatology ,Middle Aged ,medicine.disease ,Surgery ,Inguinal hernia ,Prospective clinical study ,Female ,Laparoscopy ,Radiology ,business ,Abdominal surgery - Abstract
Background: The aim of this prospective clinical study was to determine whether the presence of a hernia, its size, and its type can be established preoperatively by clinical and ultrasound, examination. Methods: The study population comprised 220 consecutive patients referred to our department for the surgical management of an inguinal hernia. On admission, both inguinal regions were examined clinically and by ultrasound. All patients were operated on laparoscopically. Results: In regard to the intraoperative findings for both inguinal regions, clinical and ultrasound examination for the diagnosis of inguinal hernia yielded a high total rate of accuracy of 93% respective 94%. However, when the same methods were used to differentiate between lateral and medial hernia, the total rate of accuracy fell to only 54% respective 62%. In the determination of inguinal hernia size, it was even lower: 50% respective 53%. Conclusions: Although a diagnosis of inguinal hernia can be established reliably by clinical and ultrasound examination, only an approximate classification is possible by these methods.
- Published
- 2002
249. Are postoperative complaints and complications influenced by different techniques in fashioning and fixing the mesh in transperitoneal laparoscopic hernioplasty? Results of a prospective randomized trial
- Author
-
K. Kraft, Reinhard Bittner, M. Ulrich, Claus Georg Schmedt, B. J. Leibl, Jens Daniel Redecke, and Barbara Kraft
- Subjects
Adult ,Male ,medicine.medical_specialty ,Visual analogue scale ,Hernia, Inguinal ,Risk Assessment ,Severity of Illness Index ,law.invention ,Postoperative Complications ,Randomized controlled trial ,law ,Reference Values ,Risk Factors ,medicine ,Humans ,Hernia ,Prospective Studies ,Laparoscopy ,Aged ,Probability ,Aged, 80 and over ,Analgesics ,Pain, Postoperative ,medicine.diagnostic_test ,business.industry ,Incidence ,Suture Techniques ,Length of Stay ,Middle Aged ,Surgical Mesh ,medicine.disease ,Surgery ,Deep inguinal ring ,medicine.anatomical_structure ,Treatment Outcome ,Anesthesia ,Abdomen ,Female ,Implant ,business ,Abdominal surgery ,Follow-Up Studies - Abstract
It is unknown at present what the best method is among mesh implantation, central incision, reconstructing the deep inguinal ring, or a non-incised mesh implant in laparoscopic hernia surgery. Further, it is unproven to what extent a circular enclosure of the cremasteric structures by an incised mesh implant could cause postoperative complications and complaints. To evaluate the possible effects of different configurations and fixation techniques of mesh implants in transperitoneal repair of inguinal hernias, a randomized trial (phase IlIa study) was conducted to compare incised versus non-incised mesh and clip fixation versus suturing the mesh. A total of 360 male patients with unilateral primary hernias were randomized to 3 groups. Postoperative complaints were documented by means of a visual analog scale. These values showed no significant differences between study arms. At the first postoperative control, on day 3, patients after repair of Nyhus type II hernias had significantly fewer complaints than those after Nyhus type IlIa and IlIb repair. To gain additional facts, a duplex flow examination of testicular vessels was performed pre- and postoperatively. Testicular perfusion was not influenced by mesh configurations in the trial. There were no statistical differences in postoperative complications and recurrence rates between groups. In conclusion no influence on postoperative complaints and complications could be demonstrated by different mesh fashioning and fixation alternatives studied in this trial.
- Published
- 2002
250. Laparoscopic transperitoneal procedure for routine repair of groin hernia
- Author
-
Jochen Schwarz, C.-G. Schmedt, B. J. Leibl, K. Kraft, and Reinhard Bittner
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Hernia, Inguinal ,Body Mass Index ,Postoperative Complications ,Recurrence ,Laparotomy ,medicine ,Humans ,Hernia ,Prospective Studies ,Prospective cohort study ,Aged ,Aged, 80 and over ,Groin ,Surrogate endpoint ,business.industry ,Mortality rate ,Length of Stay ,Middle Aged ,Hernia repair ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Treatment Outcome ,Feasibility Studies ,Female ,Clinical Competence ,Complication ,business - Abstract
Background Laparoscopic transperitoneal hernioplasty (TAPP) repair of inguinal hernias is thought to be a difficult surgical technique with high complication rates. The present study evaluated TAPP based on prospective documentation. Methods The primary aim of the study was analysis of the individual learning curve, comparing consultants with trainees. Secondary endpoints included postoperative morbidity, time of disability and rate of recurrence. Results A total of 8050 TAPP repairs have been performed since 1993. By 2001, 99·9 per cent of all hernia repairs were done by TAPP. The median operation time dropped from 50 min in the first 600 cases to 42 min thereafter. The morbidity rate decreased from 9·3 to 2·6 per cent, and the rate of recurrence from 4·8 to 0·4 per cent. Within the same interval the proportion of training procedures increased from 1·7 to 44·9 per cent in 2001. Morbidity and recurrence rates were similar for trainees and consultants. Conclusion TAPP is an effective and safe technique. It can be performed in a standard way for all inguinal and femoral hernias. The present results indicate that TAPP is possible in a routine setting, as well as in the training situation for young surgeons.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.